ARTICLE | Company News
NuOncology other research news
April 12, 1999 7:00 AM UTC
NLAB presented data showing that Arglabin inhibits farnesyl transferase, an enzyme involved in post-translational modification and activation of the Ras oncogene. The company said that inhibition of ...